Balchem Corporation (BCPC) News

Balchem Corporation (BCPC): $121.07

-1.87 (-1.52%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add BCPC to Watchlist
Sign Up

Industry: Chemicals


Ranked

of 88

in industry

Filter BCPC News Items

BCPC News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

BCPC News Highlights

  • BCPC's 30 day story count now stands at 5.
  • Over the past 21 days, the trend for BCPC's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
  • The most mentioned tickers in articles about BCPC are MSM, RAM and SKIN.

Latest BCPC News From Around the Web

Below are the latest news stories about BALCHEM CORP that investors may wish to consider to help them evaluate BCPC as an investment opportunity.

Sidoti's September Small-Cap Virtual Conference

Sidoti & Company, LLC has released the presentation schedule and weblinks for its two-day September Small-Cap Conference taking place Wednesday and Thursday, September 21-22, 2022.

Yahoo | September 20, 2022

Bears are Losing Control Over Blachem (BCPC), Here's Why It's a 'Buy' Now

Blachem (BCPC) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.

Yahoo | September 19, 2022

Balchem's (NASDAQ:BCPC) earnings growth rate lags the 12% CAGR delivered to shareholders

When we invest, we're generally looking for stocks that outperform the market average. And in our experience, buying...

Yahoo | September 4, 2022

Balchem (BCPC) Gets a Buy from H.C. Wainwright

In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Balchem (BCPC - Research Report), with a price target of $164.00. The company's shares closed yesterday at $131.82.According to TipRanks, Selvaraju is an analyst with an average return of -31.0% and a 19.54% success rate. Selvaraju covers the Healthcare sector, focusing on stocks such as Regulus, Enlivex Therapeutics, and Brainsway.Balchem has an analyst consensus of Moderate Buy, with a price target consensus of $164.00.See Insiders’ Hot Stocks on TipRanks >> The company has a one-year high of $173.80 and a one-year low of $110.15. Currently, Balchem has an average volume of 110.2K.

Austin Angelo on TipRanks | September 1, 2022

Balchem Corporation acquires Bergstrom Nutrition

NEW HAMPTON, N.Y., Aug. 30, 2022 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ:BCPC), a global specialty ingredients company focused on Nutrition and Health, today announced the acquisition of Cardinal Associates Inc., operating as “Bergstrom Nutrition,” a leading science-based manufacturer of methylsulfonylmethane (MSM), based in Vancouver, Washington. MSM is a widely used nutritional ingredient with strong scientific evidence supporting its benefits for joint health, sports nutrition, skin a

Yahoo | August 30, 2022

Best Momentum Stocks to Buy for August 24th

BCPC, KEYS and AHT made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 24, 2022.

Yahoo | August 24, 2022

H.C. Wainwright Remains a Buy on Balchem (BCPC)

In a report released today, Ram Selvaraju from H.C. Wainwright maintained a Buy rating on Balchem (BCPC - Research Report), with a price target of $164.00. The company's shares closed last Friday at $138.00.According to TipRanks, Selvaraju is an analyst with an average return of -31.8% and a 20.60% success rate. Selvaraju covers the Healthcare sector, focusing on stocks such as Regulus, Aquestive Therapeutics, and Aeterna Zentaris.Balchem has an analyst consensus of Hold.See today’s best-performing stocks on TipRanks >>Based on Balchem's latest earnings release for the quarter ending June 30, the company reported a quarterly revenue of $236.69 million and a net profit of $29.78 million.

Catie Powers on TipRanks | August 22, 2022

Should You Be Adding Balchem (NASDAQ:BCPC) To Your Watchlist Today?

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

Yahoo | July 30, 2022

Balchem (BCPC) Q2 2022 Earnings Call Transcript

Thank you for joining our conference call this morning to discuss the results of Balchem Corporation for the quarter ending June 30, 2022. My name is Martin Bengtsson, chief financial officer; and hosting this call with me is Ted Harris, our chairman, CEO, and president. Following the advice of our counsel, auditors, and the SEC, at this time, I would like to read our forward-looking statement.

Yahoo | July 30, 2022

Balchem Corporation Reports Second Quarter Sales of $236.7 Million, Net Earnings of $29.8 Million, GAAP EPS of $0.92, and Adjusted EPS of $1.07

NEW HAMPTON, N.Y., July 29, 2022 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) reported today second quarter net earnings of $29.8 million for 2022, compared to net earnings of $22.7 million for the second quarter 2021, adjusted net earnings(a) of $34.4 million, compared to $30.4 million in the prior year quarter, and adjusted EBITDA(a) of $56.5 million, compared to $50.1 million in the prior year quarter. Second Quarter 2022 Financial Highlights: Record net sales were $236.7 million, a

Yahoo | July 29, 2022


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6378 seconds.